Reuters first to report SoftBank leads latest Alto Pharmacy funding round

Reuters was first to report that SoftBank’s Vision Fund 2 was leading a $250 million investment in Silicon Valley-based startup Alto Pharmacy. SoftBank’s Vision Fund II contributed a majority of the funding round. At one point, the fund considered investing as much as $300 million but eventually decided to limit its exposure. Other existing investors in Alto, including Greenoaks Capital and Jackson Square Ventures, also participated in the Series D round.